RUNX3 and kidney cancer: Overall, the obtainedresults indicated significantly elevated expression of RUNX1 (with fold changes of 6.58 to 6.51) and RUNX3 (with fold changes of 2.7 to 8.32) in kidney cancer (Table 1).